Abstract
We studied the presence of triazole resistance of 121 Aspergillus fumigatus clinical isolates collected in two Polish cities, Warsaw and Wrocław, to determine if resistance is emerging in our country. We identified five itraconazole resistant isolates (4.13%) carrying the TR34/L98H alteration in Cyp51A gene, four of which were cross-resistant to posaconazole and one to voriconazole. One isolate was intermediate susceptible to itraconazole and harbored no Cyp51A alterations. The study confirms the presence of azole resistant A. fumigatus strains in Poland at a level that is comparative to other European countries.
Citations
-
1 5
CrossRef
-
0
Web of Science
-
1 6
Scopus
Authors (11)
Cite as
Full text
full text is not available in portal
Keywords
Details
- Category:
- Articles
- Type:
- artykuł w czasopiśmie wyróżnionym w JCR
- Published in:
-
MEDICAL MYCOLOGY
no. 56,
edition 1,
pages 1 - 4,
ISSN: 1369-3786 - Language:
- English
- Publication year:
- 2018
- Bibliographic description:
- Nawrot U., Kurzyk E., Arendrup M., Mroczyńska M., Włodarczyk K., Sulik-Tyszka B., Wróblewska M., Ussowicz M., Zdziarski P., Niewińska K., Brillowska-Dąbrowska A.: Detection of Polish clinical Aspergillus fumigatus isolates resistant to triazoles// MEDICAL MYCOLOGY. -Vol. 56, iss. 1 (2018), s.1-4
- DOI:
- Digital Object Identifier (open in new tab) 10.1093/mmy/myx012
- Verified by:
- Gdańsk University of Technology
seen 242 times
Recommended for you
Activity of isavuconazole and other triazole derivatives against clinical isolates of Aspergillus fumigatus
- U. Nawrot,,
- K. Włodarczyk,,
- M. Bartoszewicz,
- + 7 authors